Literature DB >> 9494833

New variant Creutzfeldt-Jakob disease and bovine spongiform encephalopathy.

L B Schonberger1.   

Abstract

New variant Creutzfeldt-Jakob disease (CJD) and bovine spongiform encephalopathy (BSE) are invariably fatal, subacute degenerative diseases of the brain that are classified as transmissible spongiform encephalopathies. BSE was first diagnosed in 1986 as part of an ongoing epizootic in the United Kingdom that was amplified by the feeding of rendered bovine meat-and-bone meal to young calves. As of June 1997, a total of 17 cases of new variant CJD have been reported among residents of the United Kingdom, an increase of seven cases since March 1996, when concern was first expressed about the possible emergence of new variant CJD as a novel epidemic caused by the spread of BSE to humans. Accumulating experimental and epidemiologic data support this concern and have led the CDC to support the Food and Drug Administration's efforts to modify the protein content of ruminant feed in the United States as a prudent measure to protect the health of animals and the public.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9494833     DOI: 10.1016/s0891-5520(05)70412-8

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  7 in total

1.  Structural characterization of heparins from different commercial sources.

Authors:  Fuming Zhang; Bo Yang; Mellisa Ly; Kemal Solakyildirim; Zhongping Xiao; Zhenyu Wang; Julie M Beaudet; Amanda Y Torelli; Jonathan S Dordick; Robert J Linhardt
Journal:  Anal Bioanal Chem       Date:  2011-09-20       Impact factor: 4.142

2.  Dromedary glycosaminoglycans: molecular characterization of camel lung and liver heparan sulfate.

Authors:  Mohammad Warda; Robert J Linhardt
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2005-11-17       Impact factor: 2.231

3.  Structural characterization of pharmaceutical heparins prepared from different animal tissues.

Authors:  Li Fu; Guoyun Li; Bo Yang; Akihiro Onishi; Lingyun Li; Peilong Sun; Fuming Zhang; Robert J Linhardt
Journal:  J Pharm Sci       Date:  2013-03-21       Impact factor: 3.534

Review 4.  Heparin and related polysaccharides: synthesis using recombinant enzymes and metabolic engineering.

Authors:  Matthew Suflita; Li Fu; Wenqin He; Mattheos Koffas; Robert J Linhardt
Journal:  Appl Microbiol Biotechnol       Date:  2015-07-29       Impact factor: 4.813

Review 5.  Bioengineered heparins and heparan sulfates.

Authors:  Li Fu; Matthew Suflita; Robert J Linhardt
Journal:  Adv Drug Deliv Rev       Date:  2015-11-10       Impact factor: 15.470

6.  Risk behaviors in a rural community with a known point-source exposure to chronic wasting disease.

Authors:  Ralph M Garruto; Chris Reiber; Marta P Alfonso; Heidi Gastrich; Kelsey Needham; Sarah Sunderman; Sarah Walker; Jennifer Weeks; Nicholas Derosa; Eric Faisst; John Dunn; Kenneth Fanelli; Kenneth Shilkret
Journal:  Environ Health       Date:  2008-06-24       Impact factor: 5.984

7.  Structural Characteristics and Anticoagulant Property In Vitro and In Vivo of a Seaweed Sulfated Rhamnan.

Authors:  Xue Liu; Shuyao Wang; Sujian Cao; Xiaoxi He; Ling Qin; Meijia He; Yajing Yang; Jiejie Hao; Wenjun Mao
Journal:  Mar Drugs       Date:  2018-07-20       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.